M28 Capital Management LP Activity Q4 2021-Q3 2023

Q3 2023
 Value Shares↓ Weighting
WVE SellWAVE LIFE SCIENCES LTD$40,505,875
+57.8%
7,044,500
-0.1%
46.45%
+37.0%
RCKT SellROCKET PHARMACEUTICALS INC$10,722,007
-14.4%
523,280
-17.0%
12.30%
-25.7%
BBIO SellBRIDGEBIO PHARMA INC$3,196,044
+11.8%
121,200
-27.1%
3.66%
-3.0%
NewCURIS INC$2,780,657421,9513.19%
TGTX BuyTG THERAPEUTICS INC$1,810,776
-48.8%
216,600
+52.0%
2.08%
-55.6%
STOK ExitSTOKE THERAPEUTICS INC$0-346,190-4.86%
CRIS ExitCURIS INC$0-6,000,000-6.58%
Q2 2023
 Value Shares↓ Weighting
WVE NewWAVE LIFE SCIENCES LTD$25,662,0007,050,00033.91%
RCKT NewROCKET PHARMACEUTICALS INC$12,525,651630,38016.55%
NewINVIVYD INC$9,710,6639,248,25012.83%
SWTX NewSPRINGWORKS THERAPEUTICS INC$5,183,694197,7006.85%
CRIS NewCURIS INC$4,980,0006,000,0006.58%
STOK NewSTOKE THERAPEUTICS INC$3,680,000346,1904.86%
TGTX NewTG THERAPEUTICS INC$3,539,700142,5004.68%
PRQR NewPROQR THRAPEUTICS N V$3,095,1721,910,6004.09%
BBIO NewBRIDGEBIO PHARMA INC$2,858,640166,2003.78%
ARWR NewARROWHEAD PHARMACEUTICALS IN$2,403,48467,4003.18%
SLN NewSILENCE THERAPEUTICS PLCads$2,000,900363,8002.64%
NEXI NewNEXIMMUNE INC$37,604133,4420.05%
Q4 2022
 Value Shares↓ Weighting
NEXI ExitNEXIMMUNE INC$0-133,442-0.08%
PRQR ExitPROQR THRAPEUTICS N V$0-1,001,800-0.78%
TGTX ExitTG THERAPEUTICS INC$0-338,800-2.09%
LPTX ExitLEAP THERAPEUTICS INC$0-2,664,400-2.45%
VERV ExitVERVE THERAPEUTICS INC$0-87,600-3.14%
CRIS ExitCURIS INC$0-4,482,142-3.28%
MRTX ExitMIRATI THERAPEUTICS INC$0-61,200-4.46%
BBIO ExitBRIDGEBIO PHARMA INC$0-513,300-5.33%
STOK ExitSTOKE THERAPEUTICS INC$0-522,550-7.00%
RCKT ExitROCKET PHARMACEUTICALS INC$0-665,880-11.09%
WVE ExitWAVE LIFE SCIENCES LTD$0-7,982,204-30.08%
ExitINVIVYD INC$0-9,248,250-30.22%
Q3 2022
 Value Shares↓ Weighting
BuyINVIVYD INC$28,947,000
+37.9%
9,248,250
+44.5%
30.22%
+28.4%
WVE SellWAVE LIFE SCIENCES LTD$28,816,000
+7.1%
7,982,204
-3.6%
30.08%
-0.3%
RCKT SellROCKET PHARMACEUTICALS INC$10,627,000
+7.9%
665,880
-7.0%
11.09%
+0.5%
STOK SellSTOKE THERAPEUTICS INC$6,710,000
-3.6%
522,550
-0.9%
7.00%
-10.3%
BBIO BuyBRIDGEBIO PHARMA INC$5,102,000
+20.5%
513,300
+10.1%
5.33%
+12.2%
CRIS BuyCURIS INC$3,137,000
-24.9%
4,482,142
+5.6%
3.28%
-30.1%
VERV SellVERVE THERAPEUTICS INC$3,009,000
+10.3%
87,600
-50.9%
3.14%
+2.7%
TGTX SellTG THERAPEUTICS INC$2,006,000
-35.0%
338,800
-53.3%
2.09%
-39.5%
ATRA ExitATARA BIOTHERAPEUTICS INC$0-269,253-2.35%
Q2 2022
 Value Shares↓ Weighting
WVE NewWAVE LIFE SCIENCES LTD$26,917,0008,282,20430.17%
NewADAGIO THERAPEUTICS INC$20,986,0006,398,25023.53%
RCKT NewROCKET PHARMACEUTICALS INC$9,851,000715,88011.04%
STOK NewSTOKE THERAPEUTICS INC$6,964,000527,1507.81%
BBIO NewBRIDGEBIO PHARMA INC$4,233,000466,2004.74%
CRIS NewCURIS INC$4,178,0004,243,2934.68%
MRTX NewMIRATI THERAPEUTICS INC$4,108,00061,2004.60%
TGTX NewTG THERAPEUTICS INC$3,086,000726,2003.46%
LPTX NewLEAP THERAPEUTICS INC$3,064,0002,664,4003.44%
VERV NewVERVE THERAPEUTICS INC$2,727,000178,5003.06%
ATRA NewATARA BIOTHERAPEUTICS INC$2,097,000269,2532.35%
PRQR NewPROQR THERAPEUTICS N V$779,0001,001,8000.87%
NEXI NewNEXIMMUNE INC$215,000133,4420.24%

Compare quarters

Export M28 Capital Management LP's holdings